Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers involved in the pathogenesis of cerebral small-vessel disease. | Front Neurol | 2022 | 36119691 | PubTator, text mining | PubMed |
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
| Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss. | Front Genet | 2022 | 36118846 | PubTator, text mining | PubMed |
| Regulation of Tumor and Metastasis Initiation by Chemokine Receptors. | J Cancer | 2022 | 36118530 | PubTator, text mining | PubMed |
| Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. | Signal Transduct Target Ther | 2022 | 36115852 | PubTator, text mining | PubMed |
| Fetal nuchal edema and developmental anomalies caused by gene mutations in mice. | Front Cell Dev Biol | 2022 | 36111337 | PubTator, text mining | PubMed |
| Mesenchymal stem cells derived from patients with premature aging syndromes display hallmarks of physiological aging. | Life Sci Alliance | 2022 | 36104080 | PubTator, text mining | PubMed |
| Circ_0040929 Serves as Promising Biomarker and Potential Target for Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2022 | 36101791 | PubTator, text mining | PubMed |
| Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T-lymphocytes: A bioinformatic analysis. | Front Genet | 2022 | 36092920 | PubTator, text mining | PubMed |
| The regulatory landscape of neurite development in Caenorhabditis elegans. | Front Mol Neurosci | 2022 | 36090252 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| Mutation screening of the CYP1B1 gene reveals thirteen novel disease-causing variants in consanguineous Pakistani families causing primary congenital glaucoma. | PLoS One | 2022 | 36083974 | PubTator, text mining | PubMed |
| Snail Track Lesion with Flat Keratometry in Anterior Segment Dysgenesis Caused by a Novel FOXC1 Variant. | J Clin Med | 2022 | 36079096 | PubTator, text mining | PubMed |
| A Single-Cell Survey of Cellular Heterogeneity in Human Great Saphenous Veins. | Cells | 2022 | 36078120 | PubTator, text mining | PubMed |
| Downstream Effects of Mutations in SOD1 and TARDBP Converge on Gene Expression Impairment in Patient-Derived Motor Neurons. | Int J Mol Sci | 2022 | 36077049 | PubTator, text mining | PubMed |
| Secretory SERPINE1 Expression Is Increased by Antiplatelet Therapy, Inducing MMP1 Expression and Increasing Colon Cancer Metastasis. | Int J Mol Sci | 2022 | 36076991 | PubTator, text mining | PubMed |
| The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. | J Hematol Oncol | 2022 | 36076302 | PubTator, text mining | PubMed |
| Foxc1 and Foxc2 are indispensable for the maintenance of nephron and stromal progenitors in the developing kidney. | J Cell Sci | 2022 | 36073617 | PubTator, text mining | PubMed |
| CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension. | Front Cell Dev Biol | 2022 | 36060794 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches. | Front Immunol | 2022 | 36059464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=36